Kumar Neil 的 Form 4 申報
BridgeBio Pharma, Inc.（BBIO），2026/5/26 申報
- 申報編號
- 0001470831-26-000488
- 申報時間
- 2026/5/26
- 交易日
- 2026/5/21
- 申報延遲
- 5 天
- 10b5-1 計畫
- 有勾選
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $181.2 萬。交易後 5 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kumar NeilCIK 0001742485 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/5/21 | Common Stock | S賣出處分 | −2,256 | $67.57F2 | −$152,437.92 | 267,174 | 直接 | |
| 2026/5/21 | Common Stock | S賣出處分 | −6,725 | $68.30F3 | −$459,317.5 | 260,449 | 直接 | |
| 2026/5/21 | Common Stock | S賣出處分 | −5,072 | $69.22F4 | −$351,083.84 | 255,377 | 直接 | |
| 2026/5/21 | Common Stock | S賣出處分 | −11,250 | $70.48F5 | −$792,900 | 244,127 | 直接 | |
| 2026/5/21 | Common Stock | S賣出處分 | −800 | $70.92F6 | −$56,736 | 243,327 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average sale price of the shares sold from $66.81 to $67.80 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents the weighted average sale price of the shares sold from $67.81 to $68.80 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of the shares sold from $68.81 to $69.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents the weighted average sale price of the shares sold from $69.86 to $70.85 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of the shares sold from $70.86 to $70.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。